Skip to main content
Erschienen in: Virchows Archiv 6/2012

01.12.2012 | Original Article

MicroRNA expression profiles of seminoma from paraffin-embedded formalin-fixed tissue

verfasst von: Z. Bing, S. R. Master, J. W. Tobias, D. A. Baldwin, X. W. Xu, J. E. Tomaszewski

Erschienen in: Virchows Archiv | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

In this study, we used microRNA (miRNA) microarrays in an unbiased screen for aberrantly expressed miRNAs in seminoma, a primitive type of germ cell tumor. Formalin-fixed and paraffin-embedded (FFPE) surgical samples from 11 cases of normal testicular tissue resected for nonneoplastic causes and from 11 cases of seminoma were assessed for miRNA expression. Normal testicular tissue and seminoma were paired by race. We found 112 miRNAs to be differentially expressed between seminoma and normal testicular tissue; 52 miRNAs were overexpressed, and 60, downregulated in seminoma. We did not observe significant differences between black and white populations in our race-paired study. The upregulation of the expression of hsa-mir-21, hsa-mir-372, hsa-mir-373, has-mir-221, and hsa-mir-222 was validated by reverse transcription and real-time PCR. Hsa-mir-372 was upregulated around 1,270-fold (95 % confidence interval (CI) 525.2–3,064.8; p = 8.1e-5 by Mann–Whitney U test). Hsa-mir-373 was upregulated around 1,530-fold (95 % CI 620.5–3,785.6; p = 8.0e-5 by Mann–Whitney U test), consistent with previous reports, indicating that the miRNAs in FFPE are well preserved, and FFPE can be a valuable source for the miRNA study of seminoma. In addition, expression of hsa-mir-21 (12.2-fold, 0.0095), hsa-mir-221 (3.8-fold, 0.014) and hsa-mir-222 (3.8-fold, 0.019) was found elevated in seminoma compared to normal testicular tissue.
Literatur
1.
Zurück zum Zitat McGlynn KA, Devesa SS, Sigurdson AJ et al (2003) Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97(1):63–70PubMedCrossRef McGlynn KA, Devesa SS, Sigurdson AJ et al (2003) Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97(1):63–70PubMedCrossRef
2.
Zurück zum Zitat Iczkowski KA, Butler SL (2006) New immunohistochemical markers in testicular tumors. Anal Quant Cytol Histol 28(4):181–187PubMed Iczkowski KA, Butler SL (2006) New immunohistochemical markers in testicular tumors. Anal Quant Cytol Histol 28(4):181–187PubMed
3.
4.
Zurück zum Zitat Voorhoeve PM, le Sage C, Schrier M et al (2006) A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124(6):1169–1181PubMedCrossRef Voorhoeve PM, le Sage C, Schrier M et al (2006) A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124(6):1169–1181PubMedCrossRef
5.
Zurück zum Zitat Lee EJ, Gusev Y, Jiang J et al (2007) Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120(5):1046–1054PubMedCrossRef Lee EJ, Gusev Y, Jiang J et al (2007) Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120(5):1046–1054PubMedCrossRef
6.
Zurück zum Zitat Palmer RD, Murray MJ, Saini HK et al (2010) Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. Cancer Res 70(7):2911–2923PubMedCrossRef Palmer RD, Murray MJ, Saini HK et al (2010) Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. Cancer Res 70(7):2911–2923PubMedCrossRef
7.
8.
Zurück zum Zitat Heidenreich A, Weissbach L, Holtl W et al (2001) Organ sparing surgery for malignant germ cell tumor of the testis. J Urol 166(6):2161–2165PubMedCrossRef Heidenreich A, Weissbach L, Holtl W et al (2001) Organ sparing surgery for malignant germ cell tumor of the testis. J Urol 166(6):2161–2165PubMedCrossRef
9.
Zurück zum Zitat Di Vizio D, Cito L, Boccia A et al (2005) Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. Oncogene 24(11):1882–1894PubMedCrossRef Di Vizio D, Cito L, Boccia A et al (2005) Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. Oncogene 24(11):1882–1894PubMedCrossRef
10.
Zurück zum Zitat Tang F, Hajkova P, Barton SC et al (2006) MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 34(2):e9PubMedCrossRef Tang F, Hajkova P, Barton SC et al (2006) MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 34(2):e9PubMedCrossRef
11.
Zurück zum Zitat Lehmann U (2010) MicroRNA-profiling in formalin-fixed paraffin-embedded specimens. Methods Mol Biol 667:113–125PubMedCrossRef Lehmann U (2010) MicroRNA-profiling in formalin-fixed paraffin-embedded specimens. Methods Mol Biol 667:113–125PubMedCrossRef
12.
Zurück zum Zitat Liu A, Xu X (2011) MicroRNA isolation from formalin-fixed, paraffin-embedded tissues. Methods Mol Biol 724:259–267PubMedCrossRef Liu A, Xu X (2011) MicroRNA isolation from formalin-fixed, paraffin-embedded tissues. Methods Mol Biol 724:259–267PubMedCrossRef
13.
Zurück zum Zitat Luzna P, Gregar J, Uberall I et al (2011) Changes of microRNAs-192, 196a and 203 correlate with Barrett’s esophagus diagnosis and its progression compared to normal healthy individuals. Diagn Pathol 6(1):114PubMedCrossRef Luzna P, Gregar J, Uberall I et al (2011) Changes of microRNAs-192, 196a and 203 correlate with Barrett’s esophagus diagnosis and its progression compared to normal healthy individuals. Diagn Pathol 6(1):114PubMedCrossRef
14.
Zurück zum Zitat Niyazi M, Zehentmayr F, Niemoller OM et al (2011) MiRNA expression patterns predict survival in glioblastoma. Radiat Oncol 6:153PubMedCrossRef Niyazi M, Zehentmayr F, Niemoller OM et al (2011) MiRNA expression patterns predict survival in glioblastoma. Radiat Oncol 6:153PubMedCrossRef
15.
Zurück zum Zitat Snowdon J, Zhang X, Childs T et al (2011) The microRNA-200 family is upregulated in endometrial carcinoma. PLoS One 6(8):e22828PubMedCrossRef Snowdon J, Zhang X, Childs T et al (2011) The microRNA-200 family is upregulated in endometrial carcinoma. PLoS One 6(8):e22828PubMedCrossRef
16.
Zurück zum Zitat Tetzlaff MT, Liu A, Xu X et al (2007) Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol 18(3):163–173PubMedCrossRef Tetzlaff MT, Liu A, Xu X et al (2007) Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol 18(3):163–173PubMedCrossRef
17.
Zurück zum Zitat Gillis AJ, Stoop HJ, Hersmus R et al (2007) High-throughput microRNAome analysis in human germ cell tumours. J Pathol 213(3):319–328PubMedCrossRef Gillis AJ, Stoop HJ, Hersmus R et al (2007) High-throughput microRNAome analysis in human germ cell tumours. J Pathol 213(3):319–328PubMedCrossRef
18.
Zurück zum Zitat Suh MR, Lee Y, Kim JY et al (2004) Human embryonic stem cells express a unique set of microRNAs. Dev Biol 270(2):488–498PubMedCrossRef Suh MR, Lee Y, Kim JY et al (2004) Human embryonic stem cells express a unique set of microRNAs. Dev Biol 270(2):488–498PubMedCrossRef
19.
Zurück zum Zitat Judson RL, Babiarz JE, Venere M et al (2009) Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat Biotechnol 27(5):459–461PubMedCrossRef Judson RL, Babiarz JE, Venere M et al (2009) Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat Biotechnol 27(5):459–461PubMedCrossRef
20.
Zurück zum Zitat Wang Y, Baskerville S, Shenoy A et al (2008) Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat Genet 40(12):1478–1483PubMedCrossRef Wang Y, Baskerville S, Shenoy A et al (2008) Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat Genet 40(12):1478–1483PubMedCrossRef
21.
Zurück zum Zitat Voorhoeve PM, le Sage C, Schrier M et al (2007) A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Adv Exp Med Biol 604:17–46PubMedCrossRef Voorhoeve PM, le Sage C, Schrier M et al (2007) A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Adv Exp Med Biol 604:17–46PubMedCrossRef
22.
Zurück zum Zitat Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74(6):957–967PubMedCrossRef Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74(6):957–967PubMedCrossRef
23.
24.
Zurück zum Zitat Port M, Glaesener S, Ruf C et al (2011) Micro-RNA expression in cisplatin resistant germ cell tumor cell lines. Mol Cancer 10:52PubMedCrossRef Port M, Glaesener S, Ruf C et al (2011) Micro-RNA expression in cisplatin resistant germ cell tumor cell lines. Mol Cancer 10:52PubMedCrossRef
25.
Zurück zum Zitat Huang Q, Gumireddy K, Schrier M et al (2008) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10(2):202–210PubMedCrossRef Huang Q, Gumireddy K, Schrier M et al (2008) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10(2):202–210PubMedCrossRef
26.
Zurück zum Zitat Rentoft M, Fahlen J, Coates PJ et al (2011) miRNA analysis of formalin-fixed squamous cell carcinomas of the tongue is affected by age of the samples. Int J Oncol 38(1):61–69PubMed Rentoft M, Fahlen J, Coates PJ et al (2011) miRNA analysis of formalin-fixed squamous cell carcinomas of the tongue is affected by age of the samples. Int J Oncol 38(1):61–69PubMed
27.
Zurück zum Zitat Siebolts U, Varnholt H, Drebber U et al (2009) Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR. J Clin Pathol 62(1):84–88PubMedCrossRef Siebolts U, Varnholt H, Drebber U et al (2009) Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR. J Clin Pathol 62(1):84–88PubMedCrossRef
28.
Zurück zum Zitat Li S, Liang Z, Xu L, Zou F (2012) MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases. Mol Cell Biochem 360(1–2):147–158PubMedCrossRef Li S, Liang Z, Xu L, Zou F (2012) MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases. Mol Cell Biochem 360(1–2):147–158PubMedCrossRef
29.
Zurück zum Zitat Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65(14):6029–6033PubMedCrossRef Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65(14):6029–6033PubMedCrossRef
30.
Zurück zum Zitat Frankel LB, Christoffersen NR, Jacobsen A et al (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283(2):1026–1033PubMedCrossRef Frankel LB, Christoffersen NR, Jacobsen A et al (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283(2):1026–1033PubMedCrossRef
31.
Zurück zum Zitat Asangani IA, Rasheed SA, Nikolova DA et al (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27(15):2128–2136PubMedCrossRef Asangani IA, Rasheed SA, Nikolova DA et al (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27(15):2128–2136PubMedCrossRef
32.
Zurück zum Zitat Nagao Y, Hisaoka M, Matsuyama A et al (2012) Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma. Mod Pathol 25(1):112–121PubMedCrossRef Nagao Y, Hisaoka M, Matsuyama A et al (2012) Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma. Mod Pathol 25(1):112–121PubMedCrossRef
33.
Zurück zum Zitat Niu Z, Goodyear SM, Rao S et al (2011) MicroRNA-21 regulates the self-renewal of mouse spermatogonial stem cells. Proc Natl Acad Sci U S A 108(31):12740–12745PubMedCrossRef Niu Z, Goodyear SM, Rao S et al (2011) MicroRNA-21 regulates the self-renewal of mouse spermatogonial stem cells. Proc Natl Acad Sci U S A 108(31):12740–12745PubMedCrossRef
34.
Zurück zum Zitat Elmen J, Lindow M, Silahtaroglu A et al (2008) Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 36(4):1153–1162PubMedCrossRef Elmen J, Lindow M, Silahtaroglu A et al (2008) Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 36(4):1153–1162PubMedCrossRef
35.
Zurück zum Zitat Krutzfeldt J, Rajewsky N, Braich R et al (2005) Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438(7068):685–689PubMedCrossRef Krutzfeldt J, Rajewsky N, Braich R et al (2005) Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438(7068):685–689PubMedCrossRef
36.
Zurück zum Zitat Felicetti F, Errico MC, Segnalini P, Mattia G, Care A (2008) MicroRNA-221 and −222 pathway controls melanoma progression. Expert Rev Anticancer Ther 8(11):1759–1765PubMedCrossRef Felicetti F, Errico MC, Segnalini P, Mattia G, Care A (2008) MicroRNA-221 and −222 pathway controls melanoma progression. Expert Rev Anticancer Ther 8(11):1759–1765PubMedCrossRef
37.
Zurück zum Zitat le Sage C, Nagel R, Egan DA et al (2007) Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26(15):3699–3708PubMedCrossRef le Sage C, Nagel R, Egan DA et al (2007) Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26(15):3699–3708PubMedCrossRef
38.
Zurück zum Zitat Liang Y (2008) An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer. BMC Med Genomics 1:61PubMedCrossRef Liang Y (2008) An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer. BMC Med Genomics 1:61PubMedCrossRef
39.
Zurück zum Zitat Miller TE, Ghoshal K, Ramaswamy B et al (2008) MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem 283(44):29897–29903PubMedCrossRef Miller TE, Ghoshal K, Ramaswamy B et al (2008) MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem 283(44):29897–29903PubMedCrossRef
40.
Zurück zum Zitat Zhao JJ, Lin J, Yang H et al (2008) MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem 283(45):31079–31086PubMedCrossRef Zhao JJ, Lin J, Yang H et al (2008) MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem 283(45):31079–31086PubMedCrossRef
41.
Zurück zum Zitat Garofalo M, Di Leva G, Romano G et al (2009) miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 16(6):498–509PubMedCrossRef Garofalo M, Di Leva G, Romano G et al (2009) miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 16(6):498–509PubMedCrossRef
42.
Zurück zum Zitat Zhang C, Kang C, Wang P et al (2011) MicroRNA-221 and −222 regulate radiation sensitivity by targeting the PTEN pathway. Int J Radiat Oncol Biol Phys 80(1):240–248PubMedCrossRef Zhang C, Kang C, Wang P et al (2011) MicroRNA-221 and −222 regulate radiation sensitivity by targeting the PTEN pathway. Int J Radiat Oncol Biol Phys 80(1):240–248PubMedCrossRef
Metadaten
Titel
MicroRNA expression profiles of seminoma from paraffin-embedded formalin-fixed tissue
verfasst von
Z. Bing
S. R. Master
J. W. Tobias
D. A. Baldwin
X. W. Xu
J. E. Tomaszewski
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 6/2012
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-012-1325-9

Weitere Artikel der Ausgabe 6/2012

Virchows Archiv 6/2012 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …